Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2
- PMID: 8063772
Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2
Abstract
Receptors for a variety of hematopoietins, interferons alpha/beta and gamma, and growth hormone have recently been shown to mediate rapid, ligand-dependent activation of the Janus-type cytosolic protein-tyrosine kinases Jak1, Jak2, and/or tyk-2. This finding extends relatedness among class I and II cytokine receptors to a functional context and provides an initially satisfying mechanistic analogy to protein-tyrosine kinase-encoding receptors of the epidermal growth factor/platelet-derived growth factor/insulin family. Through the construction and expression of a kinase-deficient form of Jak2 (JK2 delta VIII) in interleukin-3 (IL-3)/erythropoietin (Epo)-dependent DAER cells, we have tested whether activation of Jak2 is required for induced mitogenesis via these class I cytokine receptors. Ectopic expression of JK2 delta VIII inhibited Epo- and IL-3-induced activation of endogenous wild-type Jak2, transiently attenuated IL-3-dependent growth, and essentially abrogated Epo-induced proliferation in this model system. These dominant-negative effects provide the first direct experimental evidence for an essential role for Janus kinase activation in mitogenesis and suggest that distinct effectors may mediate IL-3-induced versus Epo-induced pathways.
Similar articles
-
The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells.J Biol Chem. 1994 Jul 15;269(28):18291-4. J Biol Chem. 1994. PMID: 8034573
-
Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation.Biochem Biophys Res Commun. 1994 Oct 14;204(1):278-83. doi: 10.1006/bbrc.1994.2456. Biochem Biophys Res Commun. 1994. PMID: 7945371
-
The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 beta-receptor chimera.J Biol Chem. 1996 Jul 12;271(28):16472-6. doi: 10.1074/jbc.271.28.16472. J Biol Chem. 1996. PMID: 8663338
-
Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway.J Biol Chem. 1995 May 12;270(19):11055-61. doi: 10.1074/jbc.270.19.11055. J Biol Chem. 1995. PMID: 7538110
-
Roles of JAK kinases in human GM-CSF receptor signal transduction.J Allergy Clin Immunol. 1996 Dec;98(6 Pt 2):S183-91. doi: 10.1016/s0091-6749(96)70065-9. J Allergy Clin Immunol. 1996. PMID: 8977526 Review.
Cited by
-
Identification of tyrosine 972 as a novel site of Jak2 tyrosine kinase phosphorylation and its role in Jak2 activation.Biochemistry. 2008 Aug 12;47(32):8326-34. doi: 10.1021/bi800867d. Epub 2008 Jul 18. Biochemistry. 2008. PMID: 18636744 Free PMC article.
-
The thrombopoietin receptor can mediate proliferation without activation of the Jak-STAT pathway.J Exp Med. 1997 Dec 15;186(12):1947-55. doi: 10.1084/jem.186.12.1947. J Exp Med. 1997. PMID: 9396763 Free PMC article.
-
GATA-1 dominantly activates a program of erythroid gene expression in factor-dependent myeloid FDCW2 cells.Mol Cell Biol. 1998 Jun;18(6):3278-88. doi: 10.1128/MCB.18.6.3278. Mol Cell Biol. 1998. PMID: 9584168 Free PMC article.
-
EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts.Blood. 2007 Oct 1;110(7):2361-70. doi: 10.1182/blood-2006-12-063503. Epub 2007 Jun 4. Blood. 2007. PMID: 17548578 Free PMC article.
-
A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6.EMBO J. 1995 Apr 3;14(7):1421-9. doi: 10.1002/j.1460-2075.1995.tb07128.x. EMBO J. 1995. PMID: 7537214 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous